AGM
LNAI

Alpine Global Management’s Lunai Bioworks LNAI Stock Holding History

Alpine Global Management’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-585
Closed -$81.9K – 408
2024
Q2 		$81.9K Buy
+585
New +$79.7K 0.01% 432
2022
Q1 		– Sell
-304
Closed -$177K – 670
2021
Q4 		$177K Buy
+304
New +$221K 0.03% 490

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Alpine Global Management's LNAI Position: Q3 2024 in Review

Alpine Global Management sold out of Lunai Bioworks (LNAI) in Q3 2024, closing a stake of 585 shares — an estimated $81.9K sold.

Alpine Global Management first reported a position in LNAI in Q4 2021 and held it in 2 quarters. The position peaked at $177K in Q4 2021. 49 funds tracked by Wall St. Rank hold LNAI as of Q3 2024.

  • Alpine Global Management reported no remaining Lunai Bioworks position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 585 Lunai Bioworks shares in Q3 2024, an estimated $81.9K.
  • Alpine Global Management first reported a position in Lunai Bioworks in Q4 2021 and held it in 2 quarters.
  • Alpine Global Management's Lunai Bioworks position peaked at $177K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.